Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy
Authors
Keywords
-
Journal
Pediatric Rheumatology
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-26
DOI
10.1186/s12969-023-00916-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- STING-Associated Vasculopathy with Onset in infancy (SAVI) Presenting as Massive Intra Alveolar Hemorrhage
- (2023) Clara Ladoux et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI)
- (2022) Clémence David et al. Cells
- The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE / PRAAS , SAVI , and AGS
- (2022) Kader Cetin Gedik et al. Arthritis & Rheumatology
- Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China
- (2022) Wendao Li et al. Frontiers in Immunology
- Role of the cGAS–STING pathway in systemic and organ-specific diseases
- (2022) Sladjana Skopelja-Gardner et al. Nature Reviews Nephrology
- Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases
- (2022) Rensheng Wan et al. Frontiers in Immunology
- STING-Mediated Lung Inflammation and Beyond
- (2021) Marie-Louise Frémond et al. JOURNAL OF CLINICAL IMMUNOLOGY
- A novel STING1 variant causes a recessive form of STING-associated vasculopathy with onset in infancy (SAVI)
- (2020) Bin Lin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Adult-Onset ANCA-Associated Vasculitis in SAVI: Extension of the Phenotypic Spectrum, Case Report and Review of the Literature
- (2020) Frederik Staels et al. Frontiers in Immunology
- Familial Interstitial Lung Disease Caused by Mutation of the STING1 Gene
- (2020) Jinying Li et al. Frontiers in Pediatrics
- Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Systematic Review of Case Reports
- (2020) YunFan Dai et al. Frontiers in Pediatrics
- Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients
- (2020) Marie-Louise Frémond et al. Journal of Allergy and Clinical Immunology-In Practice
- Stimulator of Interferon Genes-associated Vasculopathy with an Onset in Infancy Diagnosed after the Development of Atypical Pulmonary Lesions During Treatment as Juvenile Idiopathic Arthritis
- (2020) Tomoya Nishida et al. INTERNAL MEDICINE
- Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome
- (2019) Stefano Volpi et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models
- (2019) Mona Motwani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- STING-Associated Vasculopathy with Onset in Infancy in Three Children with New Clinical Aspect and Unsatisfactory Therapeutic Responses to Tofacitinib
- (2019) Xiaolei Tang et al. JOURNAL OF CLINICAL IMMUNOLOGY
- JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
- (2018) Gina A. Montealegre Sanchez et al. JOURNAL OF CLINICAL INVESTIGATION
- Pro-inflammation Associated with a Gain-of-Function Mutation (R284S) in the Innate Immune Sensor STING
- (2018) Hiroyasu Konno et al. Cell Reports
- A Mutation Outside the Dimerization Domain Causing Atypical STING-Associated Vasculopathy With Onset in Infancy
- (2018) Rohit G. Saldanha et al. Frontiers in Immunology
- Tofacitinib relieves symptoms of stimulator of interferon genes (STING)–associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173
- (2017) Jieun Seo et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Familial chilblain lupus due to a gain-of-function mutation in STING
- (2016) Nadja König et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173 -activating mutations in 3 children
- (2016) Marie-Louise Frémond et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy
- (2016) Justin Chia et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Activated STING in a Vascular and Pulmonary Syndrome
- (2014) Yin Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- The infevers autoinflammatory mutation online registry: update with new genes and functions
- (2008) Florian Milhavet et al. HUMAN MUTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now